NEW YORK (Reuters) – The following is a brief roundup of the most recent clinical studies on the novel coronavirus and efforts to discover treatments and vaccines for COVID-19, the disease caused by the infection.
FILE PHOTO: Scientists operate in a lab testing COVID-19 samples at New york city City’s health department, throughout the outbreak of the coronavirus disease (COVID-19) in New York City, New York City U.S., April 23,2020 Image taken April 23,2020 REUTERS/Brendan McDermid
New coronavirus is adapting to various populations
A genetic analysis of samples from more than 7,500 individuals infected with COVID-19 recommends that as the new coronavirus spreads rapidly around the world, it is adjusting to its human hosts, researchers reported on Tuesday in the medical journal Infection, Genetics and Evolution. They found practically 200 frequent hereditary mutations of the new coronavirus – SARS-CoV-2 – that demonstrate how it may be evolving as it spreads in people.
” All infections naturally mutate,” Francois Balloux of University College London, who co-led the research study, informed Reuters. “Mutations in themselves are not a bad thing and there is absolutely nothing to suggest SARS-CoV-2 is altering quicker or slower than expected. Far, we can not state whether SARS-CoV-2 is ending up being more or less deadly and contagious.” ( reut.rs/ 3foEOQ8 and bit.ly/ 2A63 ay3)
Experimental vaccine secures macaques from SARS-CoV-2 infection
In macaque monkeys, a speculative vaccine for the novel coronavirus securely induced antibodies that obstructed a number of different SARS-CoV-2 strains, Chinese scientists reported on Wednesday in the journal Science. The scientists state tests of their va